One‐year persistent symptoms and functional impairment in SARS‐CoV‐2 positive and negative individuals
Mayssam Nehme(University Hospital of Geneva), Thomas Agoritsas(University of Geneva), Delphine S. Courvoisier(University of Geneva), Matteo Coen, José Luís Sandoval(University of Cambridge), Frédéric Assal(University of Geneva), Riccardo Favale, Lamyae Benzakour, Nana K. Poku, Philippe Meyer(National and Kapodistrian University of Athens), Basile N. Landis(University Hospital of Geneva), Ivan Guerreiro, Pauline Vetter(University Hospital of Geneva), Marwène Grira, Silvia Stringhini(University Hospital of Geneva), Frédérique Jacquérioz(Apple (Israel)), Dina Zekry, Julien Ehrsam(University Hospital of Geneva), Jean‐Luc Reny(University Hospital of Geneva), Christophe Graf, Frédéric Lador, Aglaé Tardin, Stéphanie Baggio(University of Bern), Simon Regard(University Hospital of Geneva), Gilles Allali(University of Lausanne), Laurent Kaiser(University Hospital of Geneva), Paola M. Soccal(University of Geneva), Julien Salamun(Hôpital Beau-Séjour), Olivia Braillard(Hôpital Beau-Séjour), Guido Bondolfi(University of Geneva), François Chappuis(Hôpital Beau-Séjour), Kim Lauper(University of Geneva), Stéphane Genevay(University of Geneva), Idris Guessous(University of Geneva), Hervé Spechbach, Camille Genecand, Garance Kopp(University Hospital of Geneva)
Cited by 37
Related Papers
Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2019|5.8k
What low back pain is and why we need to pay attention
|The Lancet|2018|4.7k
Prevention and treatment of low back pain: evidence, challenges, and promising directions
|The Lancet|2018|2.5k
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update
|Annals of the Rheumatic Diseases|2022|1.9k
2022 update
|Radboud Repository (Radboud University)|2010|1.6k